Treatment of COVID‐19 induced chilblains with topical nitroglycerin
Open Access
- 20 October 2020
- journal article
- case report
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (12) , 1522-1524
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cutaneous manifestations of COVID-19: A preliminary reviewJournal of the American Academy of Dermatology, 2020
- Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology, 2020
- COVID‐19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysisClinical and Translational Medicine, 2020
- Coronavirus (COVID-19) infection–induced chilblains: A case report with histopathologic findingsJAAD Case Reports, 2020
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19New England Journal of Medicine, 2020
- ChilblainsVasa, 2020
- Vasospasm Is a Consistent Finding in Pernio (Chilblains) and a Possible Clue to PathogenesisDermatology, 2015
- Epidemiological patterns of perniosis, and its association with systemic disorderClinical and Experimental Dermatology, 2012
- Nifedipine in the treatment of chilblains.BMJ, 1986
- Corticosteroid therapy for pernioJournal of the American Academy of Dermatology, 1983